Endpoint definition
↥| Name | D3_KELA_IMMUDEF |
|---|---|
| Long name | Kela reimbursement Agammaglobulinemia (D80-84) |
| KELA reimboursements codes | 120 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 113 | 77 | 36 |
| Unadjusted prevalence (%) | 0.05 | 0.06 | 0.04 |
| Mean age at first event (years) | 42.20 | 43.94 | 38.49 |
| Case fatality at 5-years (%) | 1.77 | 1.30 | 2.78 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | - | - | - |
Survival analyses between endpoints
↥Plot
before Kela reimbursement Agammaglobulinemia (D80-84)
after Kela reimbursement Agammaglobulinemia (D80-84)
Loading survival analyses plot…
Table
Loading survival analyses table…